Hepion Pharmaceuticals, Inc. ($HEPA)
Filing Information
| Accession Number | 0001493152-26-037489 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 13, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
20,000,000
Total Value
$500,000.00
P&L
+104.0% (+$520,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 3, 2026 | Purchase | 8,000,000 | $0.05 | $400,000.00 | 14,250,000 | Indirect | By Gravitas Capital LP | View Details | |
Director | Common Stock | โ | Aug 3, 2026 | Purchase | 2,000,000 | $0.05 | $100,000.00 | 16,250,000 | Indirect | By Invictus Capital Advisors Pension Plan | View Details | |
Director | Warrants | Derivative | Aug 3, 2026 | Purchase | 8,000,000 | $0.00 | $0.00 | 8,000,000 | Indirect | By Gravitas Capital LP | View Details | |
Director | Warrants | Derivative | Aug 3, 2026 | Purchase | 2,000,000 | $0.00 | $0.00 | 10,000,000 | Indirect | By Invictus Capital Advisors Pension Plan | View Details |